Available to mentor
Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.
Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA).
-
Center MemberCaswell Diabetes Institute
-
Haas NL, Ang L, Esfandiari NH, Khan AM, Cranford JA, Cohen A, Sell J, Abdel-Hamid M, Romanchik KE, Korley FK. CHEST Critical Care, 2024 Nov; 100109Journal ArticleAnalytical Accuracy of a Continuous Glucose Monitor in Adult Diabetic Ketoacidosis
DOI:10.1016/j.chstcc.2024.100109 -
Saberi S, Esfandiari NH. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.367Journal Article5159 Bone Disease Related To PLS3 Gene Mutation
DOI:10.1210/jendso/bvae163.367 -
Kather FA, Clines GA, Janney C, Hughes DT, Esfandiari NH, Saberi S. Journal of the Endocrine Society, 2024 Oct 5; 8 (Supplement_1): bvae163.445Journal Article6722 Increase in Femoral Neck BMD After Parathyroidectomy in Patients with Mild Primary Hyperparathyroidism
DOI:10.1210/jendso/bvae163.445 -
ALIMATHUNISA ABDUL KATHER F, IYENGAR JJ, ESFANDIARI NH, BLANK R, SABERI S, KUMAR SS, GARCIA DJ, BUTLER S, JANKE EL, CIARKOWSKI SL, ANG L. Diabetes, 2024 Jun 14; 73 (Supplement_1):Journal Article1130-P: Enhancing Safety—Managing Individuals on SGLT-2 Inhibitors during the Perioperative Period
DOI:10.2337/db24-1130-p -
Esfandiari N. 2024 May 28;PresentationEndocrine Emergency in the ICU, what is new?
-
Papaleontiou M, Hodish G, Wininger M, Moretti B, Chen D, Esfandiari N, Haymart M, Papaleontiou M. Endocrine Practice, 2024 May; 30 (5): S75 - S75.Proceeding / Abstract / Poster#1704449 Double-Blinded versus Single-Blinded Peer Reviews in Endocrine Research: Does It Matter?
DOI:10.1016/j.eprac.2024.03.272 -
Papaleontiou M, Hodish G, Wininger M, Moretti B, Chen D, Esfandiari N, Haymart M, Papaleontiou M. Endocrine Practice, 2024 May; 30 (5): s75Proceeding / Abstract / Poster#1704449 Double-Blinded versus Single-Blinded Peer Reviews in Endocrine Research: Does It Matter?
DOI:10.1016/j.eprac.2024.03.272 -
Tang Y, Ang L, Jaiswal M, Dillon BR, Esfandiari NH, Shah HS, Spino C, Plunkett C, Perkins BA, Pop-Busui R, Doria A. Diabetes, 2024 May 1; 73 (5): 751 - 762.Journal ArticleCardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts.
DOI:10.2337/db23-0247 PMID: 37467433